Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation

被引：2

作者：

Nakamae, Hirohisa ^{[1
]}

机构：

[1] Osaka Metropolitan Univ, Grad Sch Med, Dept Hematol, Osaka, Japan

来源：

FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷

基金：

日本学术振兴会;

关键词：

post-transplant cyclophosphamide (PTCy); allogeneic hematopoietic cell transplantation (allo-HCT); HLA-haploidentical transplantation; HLA-matched transplantation; graft-versus-tumor (GVT) effect; LEUKEMIA WORKING PARTY; REPLETE HAPLOIDENTICAL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; BLOOD STEM-CELLS; T-CELL; PERIPHERAL-BLOOD; HOST-DISEASE; EUROPEAN-SOCIETY; DONOR AGE; HEMATOLOGIC MALIGNANCIES;

D O I：

10.3389/fimmu.2024.1403936

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Post-transplant cyclophosphamide (PTCy) is becoming the standard prophylaxis for graft-versus-host disease (GVHD) in HLA-haploidentical allogeneic hematopoietic cell transplantation (allo-HCT) and in HLA-matched allo-HCT. Immune reconstitution in the post-transplant setting may influence the graft-versus-tumor (GVT) effect because PTCy has a profound effect on T cell and natural killer cell functions and their reconstitution after allo-HCT. However, many recent studies have shown that the incidence of relapse after allo-HCT with PTCy is comparable to that after conventional allo-HCT. To further improve the outcomes, it is critical to establish a strategy to maintain or effectively induce the GVT effect when using PTCy as a platform for GVHD prophylaxis. However, there is a paucity of studies focusing on the GVT effect in allo-HCT with PTCy. Therefore, focusing on this issue may lead to the establishment of more appropriate strategies to improve transplantation outcomes without exacerbating GVHD, including novel therapies involving cell modification.

引用

页数：14

共 114 条

[1] Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide: A Systematic Review and Meta-Analysis Comparing Myeloablative with Reduced-Intensity Conditioning Regimens and Bone Marrow with Peripheral Blood Stem Cell Grafts [J].

Arcuri, Leonardo Javier ;

Hamerschlak, Nelson ;

Rocha, Vanderson ;

Bonfim, Carmem ;

Kerbauy, Mariana Nassif .

TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (09) :782.e1-782.e7

[2] Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis [J].

Arcuri, Leonardo Javier ;

Mesquita Aguiar, Marina Tayla ;

Feitosa Ribeiro, Andreza Alice ;

Fonseca Pacheco, Antonio Guilherme .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (12) :2422-2430

[3] Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation [J].

Atsuta, Yoshiko ;

Sugita, Junichi ;

Nakamae, Hirohisa ;

Maruyama, Yumiko ;

Ishiyama, Ken ;

Shiratori, Souichi ;

Fukuda, Takahiro ;

Kurata, Mio ;

Shingai, Naoki ;

Ozawa, Yukiyasu ;

Masuko, Masayoshi ;

Nagafuji, Koji ;

Takada, Satoru ;

Kako, Shinichi ;

Kanda, Yoshinobu ;

Kanda, Junya ;

Ichinohe, Tatsuo ;

Teshima, Takanori .

BONE MARROW TRANSPLANTATION, 2022, 57 (12) :1781-1787

[4] Graft versus host disease in unmanipulated haploidentical marrow transplantation with a modified post-transplant cyclophosphamide (PT-CY) regimen: an update on 425 patients [J].

Bacigalupo, Andrea ;

Raiola, Anna Maria ;

Dominietto, Alida ;

Di Grazia, Carmen ;

Gualandi, Francesca ;

Van Lint, Maria Teresa ;

Chiusolo, Patrizia ;

Laurenti, Luca ;

Sora, Federica ;

Giammarco, Sabrina ;

Angelucci, Emanuele .

BONE MARROW TRANSPLANTATION, 2019, 54 (Suppl 2) :708-712

[5] GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT [J].

Baron, Frederic ;

Labopin, Myriam ;

Tischer, Johanna ;

Raiola, Anna Maria ;

Vydra, Jan ;

Blaise, Didier ;

Chiusolo, Patrizia ;

Stoelzel, Friedrich ;

Fanin, Renato ;

Chevallier, Patrice ;

Nagler, Arnon ;

Ciceri, Fabio ;

Mohty, Mohamad .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)

[6] Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age [J].

Baron, Frederic ;

Labopin, Myriam ;

Tischer, Johanna ;

Ciceri, Fabio ;

Raiola, Anna Maria ;

Blaise, Didier ;

Sica, Simona ;

Vydra, Jan ;

Fanin, Renato ;

Stolzel, Friedrich ;

Busca, Alessandro ;

Luis Diez-Martin, Jose ;

Koc, Yener ;

Nagler, Arnon ;

Mohty, Mohamad .

AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) :1065-1074

[7] Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide [J].

Bashey, Asad ;

Zhang, Mei-Jie ;

McCurdy, Shannon R. ;

St Martin, Andrew ;

Argall, Trevor ;

Anasetti, Claudio ;

Ciurea, Stefan O. ;

Fasan, Omotayo ;

Gaballa, Sameh ;

Hamadani, Mehdi ;

Munshi, Pashna ;

Al Malki, Monzr M. ;

Nakamura, Ryotaro ;

O'Donnell, Paul V. ;

Perales, Miguel-Angel ;

Raj, Kavita ;

Romee, Rizwan ;

Rowley, Scott ;

Rocha, Vanderson ;

Salit, Rachel B. ;

Solh, Melhem ;

Soiffer, Robert J. ;

Fuchs, Ephraim Joseph ;

Eapen, Mary .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (26) :3002-+

[8] Post-Transplantation CyclophosphamideBased Graft-versus-Host Disease Prophylaxis [J].

Bolanos-Meade, J. ;

Hamadani, M. ;

Wu, J. ;

Al Malki, M. M. ;

Martens, M. J. ;

Runaas, L. ;

Elmariah, H. ;

Rezvani, A. R. ;

Gooptu, M. ;

Larkin, K. T. ;

Shaffer, B. C. ;

El Jurdi, N. ;

Loren, A. W. ;

Solh, M. ;

Hall, A. C. ;

Alousi, A. M. ;

Jamy, O. H. ;

Perales, M. -A. ;

Yao, J. M. ;

Applegate, K. ;

Bhatt, A. S. ;

Kean, L. S. ;

Efebera, Y. A. ;

Reshef, R. ;

Clark, W. ;

DiFronzo, N. L. ;

Leifer, E. ;

Horowitz, M. M. ;

Jones, R. J. ;

Holtan, S. G. .

NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25) :2338-2348

[9] The NKG2A-HLA-E Axis as a Novel Checkpoint in the Tumor Microenvironment [J].

Borst, Linda ;

van der Burg, Sjoerd H. ;

van Hall, Thorbald .

CLINICAL CANCER RESEARCH, 2020, 26 (21) :5549-5556

[10] Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial [J].

Brissot, Eolia ;

Labopin, Myriam ;

Labussiere, Helene ;

Fossard, Gaelle ;

Chevallier, Patrice ;

Guillaume, Thierry ;

Yakoub-Agha, Ibrahim ;

Srour, Micha ;

Bulabois, Claude-Eric ;

Huynh, Anne ;

Chantepie, Sylvain ;

Menard, Anne-Lise ;

Rubio, Marie-Therese ;

Ceballos, Patrice ;

Dulery, Remy ;

Furst, Sabine ;

Malard, Florent ;

Blaise, Didier ;

Mohty, Mohamad .

BLOOD CANCER JOURNAL, 2024, 14 (01)

← 1 2 3 4 5 6 7 8 9 10 →